131 related articles for article (PubMed ID: 7327794)
1. Women in drug abuse treatment programs: factors that influence retention at very early and later stages in two treatment modalities. A summary.
Moise R; Reed BG; Conell C
Int J Addict; 1981 Oct; 16(7):1295-300. PubMed ID: 7327794
[No Abstract] [Full Text] [Related]
2. Drug abuse treatment retention and process effects on follow-up outcomes.
Simpson DD; Joe GW; Rowan-Szal GA
Drug Alcohol Depend; 1997 Sep; 47(3):227-35. PubMed ID: 9306048
[TBL] [Abstract][Full Text] [Related]
3. The relation of time spent in drug abuse treatment to posttreatment outcome.
Simpson DD
Am J Psychiatry; 1979 Nov; 136(11):1449-53. PubMed ID: 495799
[TBL] [Abstract][Full Text] [Related]
4. Drug abuse treatment process: a review of the literature.
Allison M; Hubbard RL
Int J Addict; 1985 Sep; 20(9):1321-45. PubMed ID: 3000959
[TBL] [Abstract][Full Text] [Related]
5. Suspected determinants of enrollment into detoxification and methadone maintenance treatment among injecting drug users.
Schütz CG; Rapiti E; Vlahov D; Anthony JC
Drug Alcohol Depend; 1994 Oct; 36(2):129-38. PubMed ID: 7851280
[TBL] [Abstract][Full Text] [Related]
6. From theory to practice: the planned treatment of drug users. Interview by Stanley Einstein.
Woody G
Int J Addict; 1989 Jul; 24(7):675-706. PubMed ID: 2557287
[No Abstract] [Full Text] [Related]
7. [Withdrawal treatment of drug dependent patients with the aim of achieving abstinence].
Stohler R; Petitjean S; Hörler C; Bardeleben U; Ladewig D
Psychiatr Prax; 1994 Jan; 21(1):10-2. PubMed ID: 8146238
[TBL] [Abstract][Full Text] [Related]
8. The clinical connection: drugs and crime.
Leukefeld CG
Int J Addict; 1985; 20(6-7):1049-64. PubMed ID: 3908335
[TBL] [Abstract][Full Text] [Related]
9. The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program.
Raffa JD; Grebely J; Tossonian H; Wong T; Viljoen M; Khara M; Mead A; McLean M; Duncan F; Petkau AJ; DeVlaming S; Conway B
Drug Alcohol Depend; 2007 Jul; 89(2-3):306-9. PubMed ID: 17383117
[TBL] [Abstract][Full Text] [Related]
10. Weighing up the pros and cons: help-seeking by drug misusers in Baltimore, USA.
Brooke D; Fudala PJ; Johnson RE
Drug Alcohol Depend; 1992 Oct; 31(1):37-43. PubMed ID: 1330471
[TBL] [Abstract][Full Text] [Related]
11. Contingency management of supplemental drug use during methadone maintenance treatment.
Stitzer ML; Bigelow GE; Liebson IA; McCaul ME
NIDA Res Monogr; 1984; 46():84-103. PubMed ID: 6145096
[No Abstract] [Full Text] [Related]
12. Opiate maintenance and abstinence--attitudes, treatment modalities and outcome.
Ladewig D
Drug Alcohol Depend; 1990 Apr; 25(2):245-50. PubMed ID: 2328661
[No Abstract] [Full Text] [Related]
13. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
[TBL] [Abstract][Full Text] [Related]
14. Fixed and dynamic predictors of client retention in therapeutic communities.
Condelli WS; De Leon G
J Subst Abuse Treat; 1993; 10(1):11-6. PubMed ID: 8383775
[TBL] [Abstract][Full Text] [Related]
15. Methadone maintenance therapy in residential therapeutic community settings: challenges and promise.
Greenberg B; Hall DH; Sorensen JL
J Psychoactive Drugs; 2007 Sep; 39(3):203-10. PubMed ID: 18159773
[TBL] [Abstract][Full Text] [Related]
16. The effects of time in drug abuse treatment and employment on posttreatment drug use and criminal activity.
French MT; Zarkin GA; Hubbard RL; Rachal JV
Am J Drug Alcohol Abuse; 1993; 19(1):19-33. PubMed ID: 8382448
[TBL] [Abstract][Full Text] [Related]
17. Alcohol & drug abuse. HIV infection and risky sexual behaviors among women in treatment for noninjection drug dependence.
Malow RM; Jager KB; Ireland SJ; Penedo F
Psychiatr Serv; 1996 Nov; 47(11):1197-9. PubMed ID: 8916235
[No Abstract] [Full Text] [Related]
18. Buprenorphine treatment of cocaine abuse.
Kosten TR; Morgan CJ; Kleber HD
NIDA Res Monogr; 1989; 95():461. PubMed ID: 2641031
[No Abstract] [Full Text] [Related]
19. Mothers in substance abuse treatment: differences in characteristics based on involvement with child welfare services.
Grella CE; Hser YI; Huang YC
Child Abuse Negl; 2006 Jan; 30(1):55-73. PubMed ID: 16406024
[TBL] [Abstract][Full Text] [Related]
20. Agency differences in posttreatment outcomes: a follow-up of drug abuse treatment clients.
Joe GW; Singh BK; Lehman W; Simpson DD; Sells SB
Int J Addict; 1983 May; 18(4):523-38. PubMed ID: 6629561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
